Announce Date | 01/30/2025 |
EPS Normalized Actual | $0.07 (Beat by $0.01) |
EPS GAAP Actual | $0.07 (Beat by $0.01) |
Revenue Actual | $0.177872B |
Revenue Surprise | Beat by $177.872M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2028 | 1.95 | 10.93 | 1.91669 | 1.98025 | 2 |
Mar 2028 | 1.625 | 13.12 | 1.56938 | 1.79041 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.0373 | -0.0373 | 0.177872B | -43.35% | 177.87M |
FQ3 2024 (Sep 2024) | -0.18 | -0.18 | 0.187391B | -47.02% | 187.39M |
FQ2 2024 (Jun 2024) | -0.0914 | -0.0914 | 0.166919B | -66.72% | 166.92M |
FQ1 2024 (Mar 2024) | -0.0368 | -0.0368 | 0.240581B | 0.02% | 240.58M |
FQ4 2023 (Dec 2023) | 0.17 | 0.17 | 0.254984B | 2.43% | 254.98M |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 0.275509B | 13.74% | 275.51M |
FQ2 2023 (Jun 2023) | 0.32 | 0.32 | 0.278293B | 21.75% | 278.29M |
FQ1 2023 (Mar 2023) | 0.32 | 0.32 | 0.240534B | 100% | 240.53M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 0.365 | -- | 0.36453 | 0.36775 | 3 |
FQ4 2027 (Dec 2027) | 0.43 | -- | 0.41727 | 0.45261 | 3 |
FQ3 2027 (Sep 2027) | 0.34 | -- | 0.33956 | 0.34256 | 3 |
FQ2 2027 (Jun 2027) | 0.295 | -- | 0.29462 | 0.29722 | 3 |
FQ1 2027 (Mar 2027) | 0.28746 | -- | 0.28709 | 0.28963 | 3 |
FQ4 2026 (Dec 2026) | 0.40831 | -- | 0.40831 | 0.40831 | 1 |
FQ3 2026 (Sep 2026) | 0.35 | -- | 0.32536 | 0.37912 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Mar 2028) | 0.31B | -- | 0.31B | 0.31B | 1 |
FQ4 2027 (Dec 2027) | 0.33B | -- | 0.32B | 0.34B | 2 |
FQ3 2027 (Sep 2027) | 0.3B | -- | 0.3B | 0.3B | 1 |
FQ2 2027 (Jun 2027) | 0.28B | -- | 0.28B | 0.28B | 1 |
FQ1 2027 (Mar 2027) | 0.29B | -- | 0.29B | 0.29B | 1 |
FQ4 2026 (Dec 2026) | 0.33B | -- | 0.33B | 0.33B | 2 |
FQ3 2026 (Sep 2026) | 0.29B | -- | 0.27B | 0.31B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.0373 | -0.0373 | 100% | |
FQ3 2024 (Sep 2024) | -0.18 | -0.18 | 100% | |
FQ2 2024 (Jun 2024) | -0.0914 | -0.0914 | 100% | |
FQ1 2024 (Mar 2024) | -0.0368 | -0.0368 | 100% | |
FQ4 2023 (Dec 2023) | 0.17 | 0.17 | 100% | |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 100% | |
FQ2 2023 (Jun 2023) | 0.32 | 0.32 | 100% | |
FQ1 2023 (Mar 2023) | 0.32 | 0.32 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $0.18B | $177.87M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.19B | $187.39M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.17B | $166.92M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.24B | $240.58M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.25B | $254.98M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.28B | $275.51M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.28B | $278.29M | 100% |
FQ1 2023 (Mar 2023) | $0B | $0.24B | $240.53M | 100% |